Elevated NAT10 expression in pancreatic ductal adenocarcinoma (PDAC) increases the stability and enhances the expression of AXL mRNA through ac4C modification, thereby promoting pancreatic cancer progression. The gene discussed is AXL; the disease is familial pancreatic carcinoma.